potassium channel blocker
An agent that inhibits cell membrane glycoproteins that are selectively permeable to potassium ions.
|
|
anti-arrhythmia drug
A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres.
|
|
(1s,5s)- 3,7- bis(cyclopropylmethyl)- 3,7- diazaspiro[bicyclo[3.3.1]nonane- 9,1'- cyclopentane]
|